Also, given that LRRK2 is a key player in the pathogenesis of Parkinson’s disease while LRRK1 is not, the comparison of structures of both LRRK proteins may yield clues to LRRK2’s pathological functions and aid in designing novel LRRK2 targeting therapeutics. The gene discussed is LRRK2; the disease is Parkinson disease.